Published in Am J Hum Genet on July 01, 1998
The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res (2001) 2.17
The adaptive evolution of the mammalian mitochondrial genome. BMC Genomics (2008) 1.69
Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet (2000) 1.68
Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med (2012) 1.52
A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet (1999) 1.36
A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am J Hum Genet (1999) 1.20
Nonsense mutations in the COX1 subunit impair the stability of respiratory chain complexes rather than their assembly. EMBO J (2012) 1.10
Mitochondrial contribution to Parkinson's disease pathogenesis. Parkinsons Dis (2011) 1.10
Clinical mitochondrial genetics. J Med Genet (1999) 1.08
PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Hum Mol Genet (2007) 1.07
Genomics and genetics in the biology of adaptation to exercise. Compr Physiol (2011) 1.02
The genetics and pathology of mitochondrial disease. J Pathol (2016) 0.92
Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient. Neurogenetics (2005) 0.86
Mitochondrial cytochrome c oxidase deficiency. Clin Sci (Lond) (2016) 0.84
NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease. Cell Rep (2013) 0.82
Megakaryocytic differentiation of K562 cells induced by PMA reduced the activity of respiratory chain complex IV. PLoS One (2014) 0.76
Case report: a novel frameshift mutation in the mitochondrial cytochrome c oxidase II gene causing mitochondrial disorder. BMC Neurol (2017) 0.75
Polymorphisms of the murine mitochondrial ND4, CYTB and COX3 genes impact hematopoiesis during aging. Oncotarget (2016) 0.75
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci U S A (1979) 22.76
Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A (1980) 9.48
The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science (1996) 9.32
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Sequence and gene organization of the chicken mitochondrial genome. A novel gene order in higher vertebrates. J Mol Biol (1990) 5.71
Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet (1989) 4.35
RAPID EXAMINATION OF MUSCLE TISSUE. AN IMPROVED TRICHROME METHOD FOR FRESH-FROZEN BIOPSY SECTIONS. Neurology (1963) 2.98
The clinical features of mitochondrial myopathy. Brain (1986) 2.95
Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr (1997) 2.54
Structure and function of cytochrome c oxidase. Annu Rev Biochem (1990) 2.35
A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun (1990) 2.21
Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1992) 2.17
Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16
Strand asymmetry in human mitochondrial DNA mutations. Genomics (1994) 1.71
A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain (1977) 1.69
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain (1992) 1.40
Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet (1997) 1.34
A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat Genet (1996) 1.27
Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet (1994) 1.19
Mapping of heteroplasmic mitochondrial DNA deletions in Kearns-Sayre syndrome. Nucleic Acids Res (1989) 1.13
A single cell complementation class is common to several cases of cytochrome c oxidase-defective Leigh's syndrome. Hum Mol Genet (1997) 1.11
A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord (1995) 1.04
Mitochondrial disorders. Curr Opin Neurol (1996) 1.01
Molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Ann Neurol (1997) 1.01
Subunit III of cytochrome c oxidase is not involved in proton translocation: a site-directed mutagenesis study. EMBO J (1991) 1.00
Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr (1993) 0.97
Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochim Biophys Acta (1996) 0.96
Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet (1997) 0.93
Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet (1995) 0.93
Lack of transmission of deleted mtDNA from a woman with Kearns-Sayre syndrome to her child. Am J Hum Genet (1992) 0.93
Detection and analysis of mitochondrial DNA and RNA in muscle by in situ hybridization and single-fiber PCR. Methods Enzymol (1996) 0.92
Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest (1989) 0.91
Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A-->G (MERRF) mutation: relationship to proportion of mutant mitochondrial DNA. J Neurol Sci (1995) 0.85
Involvement of cytochrome c oxidase subunit III in energy coupling. Biochemistry (1995) 0.79
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet (1990) 4.96
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett (1994) 4.19
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J (1988) 3.05
The clinical features of mitochondrial myopathy. Brain (1986) 2.95
Acute pancreatitis: a lethal disease of increasing incidence. Gut (1985) 2.68
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet (1991) 2.36
Drug-induced myopathies in man. Lancet (1978) 2.25
A 25-year study of emergency surgical admissions. Ann R Coll Surg Engl (2002) 2.19
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12
Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol (1996) 2.09
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04
Pure neural tuberculoid leprosy. Br Med J (1965) 2.03
Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med (1985) 1.97
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Ion-pair extraction and high-speed liquid chromatography of cephalothin and deacetylcephalothin in human serum and urine. Drug Metab Dispos (1974) 1.94
Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol (1989) 1.88
Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology (2010) 1.88
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84
Mitochondria and degenerative disorders. Am J Med Genet (2001) 1.81
Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80
Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain (1982) 1.80
Acute cerebral oedema induced by methotrexate. BMJ (1989) 1.79
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
Splenectomy: indications, hazards and alternatives. Br J Surg (1984) 1.75
Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci (1992) 1.74
Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis (2001) 1.73
Lowering reperfusion pressure reduces the injury after pulmonary ischemia. Ann Thorac Surg (2000) 1.73
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet (2001) 1.72
Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet (2000) 1.70
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain (1977) 1.69
Genetic association studies: genes in search of diseases. Neurology (2001) 1.65
Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol (1999) 1.63
Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. J Neurol Sci (1999) 1.59
Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res (2001) 1.58
The British Isles survey of multiple sclerosis in twins. Neurology (1994) 1.57
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A (1999) 1.56
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
Acid maltase deficiency in adults. Diagnosis and management in five cases. Brain (1985) 1.56
Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry (1989) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Molecular evolution of the seed storage proteins of barley, rye and wheat. J Mol Biol (1985) 1.52
Chronic focal polymyositis in the adult. J Neurol Neurosurg Psychiatry (1981) 1.52
Glycine and neurodegenerative disease. Lancet (1991) 1.51
Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet (2000) 1.51
Neurological presentations of hypothyroidism: the importance of slow relaxing reflexes. J R Soc Med (1995) 1.51
Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51
Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol (1993) 1.49
Non-fatal subacute sclerosing leucoencephalitis. J Neurol Neurosurg Psychiatry (1968) 1.49
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann Neurol (2000) 1.49
PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology (2004) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol (2000) 1.47
Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone (2011) 1.47
Studies on the cardiotoxicity of streptolysin O. Br J Pharmacol Chemother (1968) 1.46
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol (1992) 1.45
Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol (1992) 1.45
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44
Long-term neurological complication following traumatic damage to the spinal cord with a 25 gauge whitacre spinal needle. Int J Obstet Anesth (1999) 1.44
Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ (2008) 1.44
Gold-induced neuroencephalopathy responding to dimercaprol. Lancet (1991) 1.42
Bile acid concentrations in the refluxate of patients with reflux oesophagitis. Br J Surg (1988) 1.41
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Neonatal presentation of coenzyme Q10 deficiency. J Pediatr (2001) 1.41
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest (1989) 1.41
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain (1992) 1.40
A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol (2012) 1.40
Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity. Neurology (2000) 1.40
Histological surprise: callosal tuberculoma presenting as malignant glioma. J Neurol Neurosurg Psychiatry (1997) 1.40
Endoscopic management of uterine perforation occurring during endometrial resection. Br J Obstet Gynaecol (1992) 1.39
Advances in the understanding of the cause of Parkinson's disease. J R Soc Med (1994) 1.39
A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet (1995) 1.39
Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease. Eur Heart J (1999) 1.38
Lack of benefit of very short basic drive train cycle length or repetition of extrastimulus coupling intervals for induction of ventricular tachycardia. J Cardiovasc Electrophysiol (1998) 1.38
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet (1996) 1.38
Hunting for genes in essential tremor. Eur J Neurol (2008) 1.38
Fifteen-year global time series of satellite-derived fine particulate matter. Environ Sci Technol (2014) 1.37
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol (1994) 1.36
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36
Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem (1994) 1.35